"Pfizer's Covid-19 treatment that's definitely not a profitable Ivermectin knockoff (despite both functioning as protease inhibitors) and turns out to pose an increased risk of severe illness in Covid-19 patients who have a history of cardiovascular disease."
Read Our Latest News
Do you like this post?
Showing 1 reaction
Sign in with